These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 11981760

  • 1. Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium.
    Solaun MS, Mendoza L, De Luca M, Gutierrez V, López MP, Olaso E, Lee Sim BK, Vidal-Vanaclocha F.
    Hepatology; 2002 May; 35(5):1104-16. PubMed ID: 11981760
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin].
    Zhang GF, Wang YH, Zhang MA, Wang Q, Luo YB, Wang DS, Han CR.
    Ai Zheng; 2002 Jan; 21(1):50-3. PubMed ID: 12500397
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
    Wang HH, McIntosh AR, Hasinoff BB, Rector ES, Ahmed N, Nance DM, Orr FW.
    Cancer Res; 2000 Oct 15; 60(20):5862-9. PubMed ID: 11059784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect.
    Huang X, Wong MK, Zhao Q, Zhu Z, Wang KZ, Huang N, Ye C, Gorelik E, Li M.
    Cancer Res; 2001 Jan 15; 61(2):478-81. PubMed ID: 11212235
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of antiangiogenic therapies for the prevention of liver metastases.
    Mi J, Sarraf-Yazdi S, Zhang X, Cao Y, Dewhirst MW, Kontos CD, Li CY, Clary BM.
    J Surg Res; 2006 Mar 15; 131(1):97-104. PubMed ID: 16242720
    [Abstract] [Full Text] [Related]

  • 17. The role of angiogenesis in endocrine liver metastases: an experimental study.
    Pourreyron C, Poncet G, Roche C, Gouysse G, Nejjari M, Walter T, Villaume K, Jacquier MF, Bernard C, Dumortier J, Chayvialle JA, Bachelot T, Scoazec JY.
    J Surg Res; 2008 Jan 15; 144(1):64-73. PubMed ID: 17643449
    [Abstract] [Full Text] [Related]

  • 18. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells.
    Dkhissi F, Lu H, Soria C, Opolon P, Griscelli F, Liu H, Khattar P, Mishal Z, Perricaudet M, Li H.
    Hum Gene Ther; 2003 Jul 01; 14(10):997-1008. PubMed ID: 12869217
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
    Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E, Fogler WE, Sim BK, Allred EN, Pirie-Shepherd SR, Folkman J.
    Cancer Res; 2001 Oct 15; 61(20):7669-74. PubMed ID: 11606410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.